Page 183 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 18 ฉบับที่ 2
P. 183
J Thai Trad Alt Med Vol. 18 No. 2 May-Aug 2020 405
TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee patients undergoing esophageal cancer resection. Dis
SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan Esophagus. 2011;24(3):160-5.
MH, Wang YJ, Tsai CC, Hsieh CY. Phase I clinical trial 26. Wigmore SJ, Ross JA, Falconer JS, Plester CE, Tisdale
of curcumin, a chemopreventive agent, in patients with MJ, Carter DC, Fearon KC. The effect of polyunsatura-
high-risk or pre-malignant lesions. Anticancer Res. turated fatty acids on the progress of cachexia in pa-
2001;21(4B):2895-900. tients with pancreatic cancer. Nutrition. 1996;12(Suppl.
22. Garcea G, Berry DP, Jones DJL, Singh R, Dennison 1):S27–30.
AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ. 27. Wigmore SJ, Baber MD, Ross JA, Tisdale MJ, Fearon
Consumption of the putative chemopreventive agent KC. Effect of oral eicosapentaenoic acid on weight
curcumin by cancer patients: Assessment of curcum- loss in patients with pancreatic cancer. Nutr Cancer.
in levels in the colorectum and their pharmacodynamic 2000;36(2):177-84.
consequences. Cancer Epidermiol Biomarkers Prev. 28. Persson C, Glimelius B, Rönnelid J, Nygren P. Impact
2005;14(1):120-5. of fish oil and melatonin on cachexia in patients with
23. Hsu CH, Cheng AL. Clinical studies with curcumin. Adv advanced gastrointestinal cancer: A randomized pilot
Exp Med Biol. 2007:595;471-80. study. Nutrition. 2005;21(2):170-8.
24. Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: 29. Busquets S, Carbó N, Almendro V, Quiles M T, López-
A review of anti-cancer properties and therapeutic ac- Soriano F J, Argilés J M. Curcumin, a natural product
tivity in head and neck squamous cell carcinoma. Mol present in turmeric, decreases tumor growth but dose
Cancer. 2011;10:12. not behave as an anticachectic compound in a rat model.
25. Mudge L, Isenring E, Jamieson GG. Immunonutrition in Cancer Lett. 2001 Jun 10;167(1);33-8.